$CWNM .11 News out Crown Marketing Patents Approved in

New Post Public Reply Private Reply Replies (0) Message Board
jstops

[b]$CWNM[/b] .11 News out Crown Marketing Patents Approved in Mexico

CHAPEL HILL, NC, Feb 20, 2013 (MARKETWIRE via COMTEX) -- Crown Marketing (OTCQB: CWNM) is pleased to announce that patents for its Controlled Drug Delivery Technology (CDDT) have been approved and registered in Mexico.

Mexico's pharmaceutical industry faces unique challenges. According to an American Enterprise Institute study, Mexico's $15.5 billion market is plagued by counterfeit goods. Illicit activity in Mexico's pharmaceutical industry is estimated at roughly USD 1.9 billion per year -- with counterfeiting representing 81 percent of that illicit market. This is a situation where Crown believes its unique technology could have a significant impact.

In addition to protecting Crown's interest in Mexico's burgeoning market, Crown believes that its drug delivery device would significantly inhibit the ability to counterfeit medications due to its unique form and process of manufacture.

The intellectual property supporting the Controlled Drug Delivery Technology (CDDT) is comprehensively formulated to allow for the broad application of the technology with regard to the mode of administration, the desired release pattern, the type of compounds employed and the dosage form.

The technology can be employed to regulate time to first release of drug, the extent of the initial bolus release and the duration of the remaining controlled release. These programmable release profiles may be adjusted for considerations given to the different gastric and intestinal environments.

Crown's patent portfolio continues to increase as it is pursuing novel applications of its drug delivery technology.

About The Company:

Crown Marketing Crown's Controlled Drug Delivery Technology (CDDT) is a novel controlled-release technology, harnessing the principles diffusion through precise mathematical formulas. The spectrum and reliability of pharmacokinetic profiles achievable with this technology is superior to currently marketed formulations. Its simple design allows for a high level of flexibility in matching chronotherapeutic requirements. Cost-efficiencies in the commercial manufacturing process, when compared to other drug delivery technologies, may constitute its most important competitive advantage.

The objective of intelligent drug delivery design amounts to maximizing the percent of the time drug plasma levels are within the therapeutic range and avoiding patient exposure to potentially toxic (High) or sub-therapeutic (Low) levels.

Crown's cost-effective application of controlled delivery technologies will play a major role in the expansion of the pharmaceutical, OTC and nutraceuticals industry through our ability to improve on the performance of immediate release products in a manner tangible to manufacturers and consumers.

More information can be found at: www.crowncddt.com

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contact:

Charles Van Der Ross

347-491-0565

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 255

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 339

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 215

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 169

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 266

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 209

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 156

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 232

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Runway Growth Finance Highlights Portfolio Performance 2025

Updated Category News Views 258

Overview of Runway Growth Finance Corp. Runway Growth Finance Corp. (NASDAQ: RWAY) is paving its path as a leading provider of flexible capital solutions aimed at late- and growth-stage companies. Their mission is to present an alternative for businesses looking to raise equity, and they have recently shared their quarterly operational update for the period ending June...

Continue Reading
Market Anticipation: Fed's Expected Interest Rate Moves

Updated Category News Views 113

Federal Reserve's Interest Rate Decisions in Focus The upcoming meeting of the Federal Reserve is drawing considerable interest from economists and investors. Everyone is keenly awaiting the outcome regarding potential interest rate cuts as market conditions continue to shift. With the discussion around monetary policy heating up, there’s a range of opinions on how...

Continue Reading
Argon Medical Makes Progress with Innovative PE Treatment Trial

Updated Category News Views 361

Argon Medical Devices Launches CLEAN-PE Study for Pulmonary Embolism Argon Medical Devices is making significant strides in the medical field with its recent announcement of the first patient enrollment in the CLEAN-PE study. This prospective and multicenter study is designed to test the Cleaner™ Pro Thrombectomy System, which aims to effectively address pulmonary...

Continue Reading
Citi Adjusts PBF Energy Stock Target as Market Challenges Emerge

Updated Category News Views 53

Citi Revises Price Target for PBF Energy Recently, Citi has made a noteworthy adjustment to the price target for PBF Energy (NYSE: PBF), reducing it from $48.00 to $37.00. This update follows an extensive review of the refining company's financial model against the backdrop of fluctuating commodity prices. Despite this shift, Citi maintains a Neutral rating on the stock,...

Continue Reading
Clip Total 3: Revolutionizing Mobile Payments for Businesses

Updated Category News Views 174

Introducing Clip Total 3: A Game-Changer for Businesses Clip, the prominent digital commerce platform in Mexico, has recently launched the Clip Total 3, marking a significant leap in mobile point-of-sale technology for businesses across various sectors. This next-generation device is designed not only for payment acceptance but also for comprehensive business management....

Continue Reading